We are live on ! Find out more
OGEN icon

Oragenics
OGEN

24 hedge funds and large institutions have $3.61M invested in Oragenics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

8% less funds holding

Funds holding: 26 → 24 (-2)

27% less capital invested

Capital invested by funds: $4.96M → $3.61M (-$1.35M)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$31.5K
2
State Street
State Street
Massachusetts
+$14.7K
3
Jane Street
Jane Street
New York
+$6.6K
4
UBS Group
UBS Group
Switzerland
+$5.13K
5
Millennium Management
Millennium Management
New York
+$2.93K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$183K
2
VF
Virtu Financial
New York
-$60.9K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$36K
4
Citadel Advisors
Citadel Advisors
Florida
-$24K
5
TSS
Two Sigma Securities
New York
-$15.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.74M -$9.53K -13 -0.5%
SBF
2
Sara-Bay Financial
Florida
$692K – – –
BlackRock
3
BlackRock
New York
$453K +$733 +1 +0.1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$251K – – –
State Street
5
State Street
Massachusetts
$171K +$14.7K +20 +8%
Northern Trust
6
Northern Trust
Illinois
$62K – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$54K – – –
BCM
8
Bridgeway Capital Management
Texas
$48K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$33K +$31.5K +43 +391%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$26K +$2.2K +3 +8%
Jane Street
11
Jane Street
New York
$17K +$6.6K +9 +47%
VF
12
Virtu Financial
New York
$14K -$60.9K -83 -79%
UBS Group
13
UBS Group
Switzerland
$11K +$5.13K +7 +70%
TSS
14
Two Sigma Securities
New York
$10K -$15.4K -21 -55%
BSW
15
Buckingham Strategic Wealth
Missouri
$9K – – –
Millennium Management
16
Millennium Management
New York
$6K +$2.93K +4 +67%
Victory Capital Management
17
Victory Capital Management
Texas
$5K – – –
SWA
18
Strategies Wealth Advisors
Michigan
$3.45K – – –
Verition Fund Management
19
Verition Fund Management
Connecticut
$3K – – –
SWM
20
Spire Wealth Management
Virginia
$2K -$2.93K -4 -50%
TFGT
21
TS Financial Group (TSFG)
Illinois
$1K – – –
NDSI
22
Newman Dignan & Sheerar Inc
Rhode Island
$4 – – –
GCP
23
GSA Capital Partners
United Kingdom
– -$183K -228 Closed
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
– -$36K -44 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$24K -30 Closed
1
2

OGEN Hedge Fund Activity: Q1 2022 in Review

24 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2022, worth a combined $3.61M — down 27% from $4.96M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OGEN and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $31.5K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $183K sold.

  • 24 institutional investors held Oragenics (OGEN) as of Q1 2022, down from 26 in Q4 2021.
  • Funds reported $3.61M of Oragenics stock for Q1 2022, down 27% quarter-over-quarter.
  • 1 fund opened new Oragenics positions in Q1 2022 and 3 closed out, a net change of -2 holders.
  • The largest Oragenics buyer in Q1 2022 was Renaissance Technologies, an estimated $31.5K added.
  • The largest Oragenics seller in Q1 2022 was GSA Capital Partners, an estimated $183K sold.

Based on aggregated 13F filings for Q1 2022.